Amylyx Pharmaceuticals, Inc. AMLX Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s software and technology licenses, net?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported software and technology licenses, net of $2.5M in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s software and technology licenses, net changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s software and technology licenses, net increased by 22627.3% year-over-year, from $11K to $2.5M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s software and technology licenses, net?
- Over 3 years (2022 to 2025), Amylyx Pharmaceuticals, Inc.'s software and technology licenses, net has grown at a 75.0% compound annual growth rate (CAGR), from $466K to $2.5M.